Modelling mutational landscapes of human cancers in vitro
Magali Olivier(Centre international de recherche sur le cancer), Jiří Zavadil(Centre international de recherche sur le cancer), John Alexander(University of Florida), Maude Ardin(Centre international de recherche sur le cancer), Graham Byrnes(Centre international de recherche sur le cancer), Lee Hazelwood(University of Leeds), Maxime Vallée(Hospices Civils de Lyon), Hana Hušková(Charles University), Hiroyuki Marusawa, Annette Weninger(German Cancer Research Center), James McKay(Centre international de recherche sur le cancer), Karl–Rudolf Muehlbauer(German Cancer Research Center), Xavier Castells(Red de Investigación en Actividades Preventivas y Promoción de la Salud), Monica Hollstein(Universitätsmedizin Göttingen), Tatiana Nedelko(German Cancer Research Center)
Cited by 98
Related Papers
TP53 Mutations in Human Cancers: Origins, Consequences, and Clinical Use
|Cold Spring Harbor Perspectives in Biology|2009|2.2k
A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25
|Nature|2008|1.3k
Global burden of cancer attributable to high body-mass index in 2012: a population-based study
|The Lancet Oncology|2014|994
Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes
|Nature Genetics|2017|804
A Genome-wide Association Study of Lung Cancer Identifies a Region of Chromosome 5p15 Associated with Risk for Adenocarcinoma
|The American Journal of Human Genetics|2009|510